Replies to Post #6601 onArbutus Biopharma Corporation (ABUS) | InvestorsHub

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Replies to post #6601 on Arbutus Biopharma Corporation (ABUS)

Replies to #6601 on Arbutus Biopharma Corporation (ABUS)

05/05/22 4:00 PM

#6602 RE: DewDiligence #6601

ABUS 1Q22 CC transcript:

https://www.fool.com/earnings/call-transcripts/2022/05/05/arbutus-biopharma-abus-q1-2022-earnings-call-trans/

08/04/22 3:53 PM

#6612 RE: DewDiligence #6601

ABUS 2Q22 results—6/30/22 cash=$200.6M—(down from $222M @3/31/22):

https://finance.yahoo.com/news/arbutus-reports-second-quarter-2022-113000120.html